Works matching IS 09024441 AND DT 2023 AND VI 111 AND IP 3
Results: 23
Efficacy of COVID‐19 vaccination in adult patients with sickle cell disease during the Omicron wave in France.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 509, doi. 10.1111/ejh.14034
- By:
- Publication type:
- Article
Improved serologic responses to DTaP over Tdap vaccination in adult hematopoietic cell transplant recipients.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 499, doi. 10.1111/ejh.14033
- By:
- Publication type:
- Article
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 491, doi. 10.1111/ejh.14032
- By:
- Publication type:
- Article
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 485, doi. 10.1111/ejh.14031
- By:
- Publication type:
- Article
Anakinra versus etoposide‐based therapy added to high‐dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 477, doi. 10.1111/ejh.14030
- By:
- Publication type:
- Article
Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 458, doi. 10.1111/ejh.14029
- By:
- Publication type:
- Article
Molecular regulatory mechanisms of erythropoiesis and related diseases.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 337, doi. 10.1111/ejh.14028
- By:
- Publication type:
- Article
Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 449, doi. 10.1111/ejh.14027
- By:
- Publication type:
- Article
Molecular pharmacology in complement‐mediated hemolytic disorders.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 326, doi. 10.1111/ejh.14026
- By:
- Publication type:
- Article
High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia‐negative myeloproliferative neoplasms.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 400, doi. 10.1111/ejh.14019
- By:
- Publication type:
- Article
Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016–2020.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 441, doi. 10.1111/ejh.14025
- By:
- Publication type:
- Article
Hematopoietic cell transplantation for telomere biology diseases: A retrospective single‐center cohort study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 423, doi. 10.1111/ejh.14023
- By:
- Publication type:
- Article
Relationship between hemoglobin, hemolysis, and transcranial Doppler velocities in children with sickle cell disease: Results from a long‐term natural history study in Italy in the era of multimodal therapy.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 414, doi. 10.1111/ejh.14022
- By:
- Publication type:
- Article
Cyclosporine plus eltrombopag in the treatment of aplastic anemia with or without antithymocyte immunoglobulin: A multicenter real‐world retrospective study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 407, doi. 10.1111/ejh.14021
- By:
- Publication type:
- Article
Possible role of IL‐23 inhibitor in autoimmune hemolytic anemia.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 506, doi. 10.1111/ejh.14020
- By:
- Publication type:
- Article
Outcomes of COVID‐19 hospitalizations in patients with sickle cell disease: A nationwide analysis.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 432, doi. 10.1111/ejh.14024
- By:
- Publication type:
- Article
Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real‐world Swedish population receiving modern treatment.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 391, doi. 10.1111/ejh.14018
- By:
- Publication type:
- Article
A multimodal pain protocol for treatment of vaso‐occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 382, doi. 10.1111/ejh.14017
- By:
- Publication type:
- Article
Bone marrow Ki‐67 index is of prognostic value in newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 373, doi. 10.1111/ejh.14016
- By:
- Publication type:
- Article
Venetoclax‐based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 365, doi. 10.1111/ejh.14015
- By:
- Publication type:
- Article
Efficacy and safety of PD‐1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 356, doi. 10.1111/ejh.14013
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of an oral formulation of decitabine and tetrahydrouridine.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 345, doi. 10.1111/ejh.14009
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 323, doi. 10.1111/ejh.13799
- Publication type:
- Article